论文信息 - Activin Type II Receptor Ligand Signaling Inhibition After Experimental Ischemic Heart Failure Attenuates Cardiac Remodeling and Prevents Fibrosis. - 字舞流文

Activin Type II Receptor Ligand Signaling Inhibition After Experimental Ischemic Heart Failure Attenuates Cardiac Remodeling and Prevents Fibrosis.

Z. Ali | S. Homma | H. Sweeney | P. Schulze | G. Ferrari | H. Akashi | Isaac J George | E. Castillero | P. Colombo | Xianghai Liao | M. Najjar | R. Ji | Xiaokan Zhang | Lea Maria Brandstetter | Catherine Wang | A. Sperry | Marcia Gailes | Karina Guaman | Adam Recht | Ira Schlosberg | Isaac George